Interleukin-8 (IL-8) is a key inflammatory chemokine significantly linked to prostate health, promoting inflammation in Benign Prostatic Hyperplasia (BPH) and driving the growth, metastasis, and treatment resistance (especially to androgen therapies) in prostate cancer (PCa).